Recurrence in Cervical High-Grade Squamous Intraepithelial Lesion: The Role of The Excised Endocervical Canal Length - Analysis of 2,427 Patients
Recurrence in Cervical High-Grade Squamous Intraepithelial Lesion: The Role of The Excised Endocervical Canal Length - Analysis of 2,427 Patients
Recurrence in Cervical High-Grade Squamous Intraepithelial Lesion: The Role of The Excised Endocervical Canal Length - Analysis of 2,427 Patients
Journal of Lower Genital Tract Disease • Volume 27, Number 1, January 2023 1
disease and to find a cut-off point above which lower recurrence - Exclusion criteria: colposcopy-directed biopsy showing a dif-
rates could be observed associated with low probability of ferent report of CIN 2 or 3 (excluding reports of cervicitis and
compromising the obstetric outcome. microinvasive cancer); patients with clinical follow-up shorter
than 18 months.
2 © 2022, ASCCP
TABLE 1. Global Sample Epidemiological Data (n = 2,427 TABLE 3. Relationship of Data Related to the Surgical Specimen
Cases) With HSIL Relapses/Recurrence
© 2022, ASCCP 3
FIGURE 2. The ROC curve for all sample/cut-off point for the canal length from which the HSIL recurrence rate increases.
with compromised margins, relapses occurred in 116 (37.7%) and related to the chance of relapse. All these data can be seen in
in 196 (9.2%) in those with free margins, and it was statistically Table 2.
significant ( p < .001). Recurrence occurred in 311 of the 2,427 patients, repre-
The epidemiological data and those related to the product of senting 12.8%. The average time to relapse was 13 months
conization can be seen in Table 1. ±12.5 months. Relapse was 52% at 10 months, 62.5% at
Epidemiological data show that age and parity were sta- 12 months, and 80.4% at 18 months, considering that only pa-
tistically significant to disease recurrence, whereas smoking tients who had follow-up beyond 18 months were included.
was not. The presence of HIV was demonstrated to be highly The positivity of HIV was a significant factor for recurrence
significant in association with relapsing. Regarding the ex- ( p < .001), with relapse occurring in 12% of seronegative and
cised specimen data, it was observed that the biopsy histolog- 43% of seropositive patients.
ical report and volume were not related to recurrence rates. On The study showed that there was a significant difference
the other hand, margin impairment and canal length were directly between relapses and nonrelapses in relation to canal length,
TABLE 5. The Recurrence Probability (OR) for Treated HSIL in Relation to Canal Length, HIV Seropositivity, and Margins of the
Conization Product
4 © 2022, ASCCP
although the analysis of the total volume of the piece did not defined cut-off point, we may have contributed to the reduction of
show such association, as can be seen in Table 3. obstetric comorbidities and lower recurrence rates.
As evidenced in the literature that the chance of relapsing is In addition to these main data found on the minimum length
higher in patients with compromised margins and HIV,11 based of the excised canal, we found a direct relationship between HIV
on the analysis of the canal length as a function of the relapse rate, and margin impairment (6.67 and 5.99 times, respectively) and re-
these patients were excluded, comprising a population that was currence rate, demonstrating the credibility of the data presented
called “purified population.” It could be argued that the possibility in agreement with the literature regarding these factors (HIV and
of greater margin compromise would be associated with the margins impairment) and relapse rates.
shorter length of the removed canal. After statistical analysis, it Within the same reasoning, it could be inferred that in
was shown that there was a correlation between excised cervical manufacturing the handles used in these procedures, it ideally
canal length and chance of relapsing. could be calibrated for confection higher than 1.25 cm in relation
We observed that the resected volume of the piece was not to their height.
statistically significant; therefore, we focused on the length of At this time, after data analysis, the study concluded that:
the canal, and that was the main object of the study analysis as
shown in Table 4. 1. The excised canal length is directly related to the relapse rates;
To evaluate if there was a certain cut-off point of the excised 2. An excised canal length of 1.25 cm or longer was associated
canal length that was associated with higher chance of recurrence, with a lower recurrence rate;
the data were analyzed using an ROC curve, as can be seen in 3. Human immunodeficiency virus and compromised mar-
Figure 2. The graph shows the ROC curve of the general popula- gins presented with 6.67 and 5.99 times higher chance of
tion showing that 1.25 cm or longer of canal resection would have recurrence, respectively.
a lower chance of recurrence.
In an attempt to evaluate the chance of relapse in relation to
the factors listed in Table 5, we observed the odds ratio of each
factor as a function of recurrence. The study demonstrated that
the presence of compromised margins increases the risk of relapse REFERENCES
by 5.99 times ( p < .001; 95% CI = 4.55–7.87). The presence of
1. Ministério da Saúde; Instituto Nacional do Cancer (Brasil). Estimativa
HIV increases the risk of relapse by 6.67 times ( p < .001; 95%
2018. Incidência do Câncer no Brasil. Rio de Janeiro, Brazil: INCA; 2016.
CI = 3.93–11.29). When the length of the excised canal is shorter
than 1.25 cm, the risk of recurrence increases by 2.55 times (95% 2. Kolf C. QnAs with Harald zur Hausen. Proc Natl Acad Sci U S A 2012;
CI = 1.42–4.58). 109:1378.
As limiting factors, we suggest that this was a retrospective 3. International Agency for Research on Cancer. Monographs of Evaluation
study, in which the pieces were evaluated and the canal length of Carcinogenetic Risks to Humans. Lyon, France: IARC; 2007;90:1–689.
was measured without a planned association with recurrence rates. 4. The revised Bethesda System for reporting cervical/vaginal cytologic
Moreover, the fact that we did not link to the location of the le- diagnoses: report of the 1991 Bethesda workshop. Acta Cytol 1992;36:
sions, if ectocervical or endocervical (intracanal), may suggest 273–6.
to us that in the latter, canal length value may be underestimated. 5. Richart RM. Natural history of the cervical intraepithelial neoplasia. Clin
The procedures were performed by various health profes- Obstet Gynecol 1967;10:748–84.
sionals, and the anatomopathological specimen was evaluated by
6. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is
different sets of pathologists; this interoperator/interobserver
a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;
“bias” is likely overcome by sample size. 189:12–9.
7. Villa LL. Human papillomaviruses and cervical cancer. Adv Cancer Res
1997;71:321–41.
DISCUSSION AND CONCLUSIONS 8. Moscicki AB, Shiboski S, Broering J, et al. The natural history of human
Because of the dilemma between the lower chance of recur- papillomavirus infection as measured by repeated DNA testing in
rence of cervical lesion (CIN) and the possibility of increasing adolescent and young women. J Pediatr 1998;132:277–84.
the rate of prematurity, the excision of the canal should not be less 9. Muñoz N, Bosch FX. HPV and cervical neoplasia: review of case-control
than that sufficient to prevent recurrence of the lesion (high-grade and cohort studies. IARC Sci Publ 1992;251–61.
CIN) and not greater than that which could increase the risk of 10. Fonseca FV, Tomasich FD, Jung JE, et al. The role of P16 ink4a and P53
prematurity rate. immunostaining in predicting recurrence of HG-CIN after conization
Therefore, based on this rationale, the goal of this study and treatment. Rev Col Bras Cir 2016;43:35–41.
as-found novelties has shown the direct relationship between the 11. Gonzales DIJr., Zahn CM, Retzloff MG, et al. Recurrence of dysplasia after
measurement of the excised (resected) canal length and the recur- loop electrosurgical excision procedures with lon-term follow-up. Am J
rence after conization. Obstet Gynecol 2001;184:315–21.
Among the excised canal measurements, the cut-off point of
12. Milojkovic M. Residual and recurrent lesions after conization for cervical
1.25 cm was obtained, below which recurrence rates increased by
intraepithelial neoplasia grade 3. Int J Gynaecol Obstet 2002;76:49–53.
2.55 times, and these data have not yet been found in the literature.
Among the perspectives, it is important to highlight that be- 13. Maluf PJ, Adad SJ, Murta EF. Outcome after conization for cervical
sides countless variables already shown in the literature, which in- intraepithelial neoplasia grade III: relation with surgical margins, extension
crease recurrence after conization, the length of the canal also pre- to the crypts and mitoses. Tumori 2004;90:473–7.
sents this assertion. 14. Alonso I, Torné A, Puig-Tintoré LM, et al. High-risk cervical epithelial
This study opens perspectives so others can evaluate this neoplasia grade 1 treated by loop electrosurgical excision: follow-up and
finding in other samples and other populations (the canal length value of HPV testing. Am J Obstet Gynecol 2007;197:359.e1–6.
cut-off point). 15. Bae JH, Kim CJ, Park TC, et al. Persistence of human papillomavirus as a
In addition, because we know that the shorter the excised ca- predictor for treatment failure after loop electrosurgical excision procedure.
nal length, the better the obstetric future, we believe that with this Int J Gynecol Cancer 2007;17:1271–7.
© 2022, ASCCP 5
16. Costa S, De Simone P, Venturoli S, et al. Factors predicting human 21. Gatta LA, Kuller JÁ, Rhee EHJ. Pregnancy outcomes following cervical
papillomavirus clearance in cervical intraepithelial neoplasia lesions treated conization or loop electrosurgical excision procedures. Obstet Gynecol
by conization. Gynecol Oncol 2003;90:358–65. Surv 2017;72:494–9.
17. Gardeil F, et al. Persistent intraepithelial neoplasia after excision for cervical 22. Kyrgiou M, Athanasiou A, Paraskevaidi M, et al. Adverse obstetric
intraepithelial neoplasia grade III. Obstet Gynecol 1997;89:419–22. outcomes after local treatment for cervical preinvasive and early invasive
18. Lin C, Tseng CJ, Lai CH, et al. Value of human papillomavirus deoxyribonucleic disease according to cone depth: systematic review and meta-analysis. BMJ
acid testing after conization in the prediction of residual disease in the subsequent 2016;28:354–i3633.
hysterectomy specimen. Am J Obstet Gynecol 2001;184:940–5. 23. Baldauf JJ, Baulon E, Thoma V, et al. Obstetric outcomes LOOP-excision.
19. Mitchell MF, Tortolero-Luna G, Cook E, et al. A randomized clinical trial of J Gynecol Obstet Biol Reprod (Paris) 2013;42:534–40.
cryotherapy, laser vaporization, and loop electrosurgical excision for treatment of 24. Prendiville W, Cullimore J, Norman S. Large loop excision of
squamous intraepithelial lesions of the cervix. Obstet Gynecol 1998;92:737–44. transformation zone (LLETZ). A new method of management for
20. Nuovo J, Melnikow J, Willan AR, et al. Treatment outcomes for squamous women with cervical intraepithelial neoplasia. Br J Obstet Gynaecol
intraepithelial lesions. Int J Gynaecol Obstet 2000;68:25–33. 1989;96:1054–60.
6 © 2022, ASCCP